Companies / Immunome Inc.

Immunome Inc.

Nasdaq: IMNMCIK 1472012BOTHELL, WA

Financials · FY2025

Revenue$6.94M
Net income$-212.39M
Total debt$500.0K
Cash$217.71M
Diluted EPS$-2.43
Shares outstanding113.6M

Ownership

113.6M shares outstanding · as of Aug 6, 2026
0.91%Insiders
Ownership
Insiders0.91%1,031,851
Institutions106.84%121,350,650
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Siegall Clay BCEOPresident and CEO · Director
0.61%690,704
0.30%341,147
Bienaime Jean JacquesFormerDirector
0.04%43,415

Institutional holders 189

View all →
HolderValue% of shares
Fmr LLC$355.49M14.57%
BlackRock, Inc.$186.59M7.75%
Point72 Asset Management, L.P.$151.11M6.19%
Vanguard Group Inc$129.71M5.32%
Redmile Group, LLC$122.83M5.03%
State Street Corporation$116.43M4.84%
Enavate Sciences GP, LLC$102.43M4.20%
Primecap Management CO/CA$100.64M4.13%
Driehaus Capital Management LLC$79.60M3.26%
JPMORGAN CHASE & CO$61.34M2.51%

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 20, 2026Philip Wagenheim
Director
SellCommon Stock$753.3K-37K
-9.06%
369,347
0.33% of shares
medium
Mar 23, 2026Philip Wagenheim
Director
SellCommon Stock$582.3K-28K
-7.64%
341,147
0.30% of shares
medium
Mar 27, 2026Siegall Clay B
CEO
BuyCommon Stock$500.6K+25K
+3.83%
690,704
0.61% of shares
high
Jun 5, 2026Bienaime Jean Jacques
Director
SellCommon Stock$194.1K-10K
-23.30%
32,915
0.03% of shares
medium
Jun 5, 2026Bienaime Jean Jacques
Director
BuyCommon Stock$116.9K+6K
+18.23%
38,915
0.03% of shares
medium
May 15, 2026Bienaime Jean Jacques
Director
BuyCommon Stock$103.5K+5K
+13.02%
43,415
0.04% of shares
medium
Jun 5, 2026Bienaime Jean Jacques
Director
BuyCommon Stock$68.1K+4K
+8.99%
42,415
0.04% of shares
medium
Mar 10, 2026Bienaime Jean Jacques
Director
BuyCommon Stock$22.1K+1K
+2.75%
37,415
0.03% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A0
Redmile Group, LLCPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
IMNM45257U108